The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

Organizational structure

CDDF is a unique organization leveraging a tripartite approach, which includes senior academic oncology specialists,  industry and scientific panels and representatives from regulatory authorities with the goal to create an “ideal” scientific, regulatory and commercial forum for the clinical development of cancer drugs.

CDDF board members are distinguished and experienced pre-clinical and clinical investigators who are devoted to the development of cancer drugs. They have experience in giving advice or reviewing on drug development strategies in pre-clinical and early clinical development, designing phase I/IIl clinical trials using novel designs and endpoints to speed up and optimise the overall drug development programmes, and to avoid suboptimal drug development strategies.


The CDDF office is located in Brussels and is composed of staff members and a managing director:

Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752
Tel: +32 2 880 62 70